Hair Relaxer Uterine Fibroids Lawsuits

CALL 24/7(888) 348-2735

Hair Relaxer Lawsuit — Free, Confidential Consultation

Fibroids after years of relaxers.

Straight answer first: fibroid claims are outside the federal trial track and have not been dismissed — they are worked up and monitored. That is the structure of the litigation, not a verdict on you. Two minutes tells you where yours stands.

Active litigation — no settlement. MDL 3060 underway · 11,779 cases pending · filing deadlines vary by state and run from when you knew or should have known.

Did you get relaxers — perms, the white cream — every few weeks, for years?

That one question decides most of it. It seems like nobody ever told you the risk was anything worse than a scalp burn.

See where I standfree · confidential · 2 minutes · an honest answer either way
What the lawsuit is actually about →

No receipts needed · you don’t have to remember every brand · no fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Or talk to a person now: (888) 348-2735 — answered 24/7

Marin & Murphy Law Firm

Every inquiry gets a personal review and a straight answer — including “not yet” or “no” — free and without obligation.

Claims are brought against the companies that made and sold chemical relaxers — not against your stylist, your salon, or the person who did your hair growing up. Conversations are confidential. Some matters may be referred to or handled with other law firms. No settlement has been announced and no trial has been held; every case depends on its own facts. This page does not diagnose anything. Attorney Advertising.

This page is about a lawsuit — it is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

Lawsuits consolidated in federal court in Chicago (MDL 3060) allege that long-term use of chemical hair relaxers is associated with uterine cancer, ovarian cancer, and related conditions. As of August 2026 the cases are in pretrial proceedings; no trial has been held and no settlement has been announced. The allegations have not been proven, and each case depends on its own facts.

The straight answer on fibroid claims

Fibroids, endometriosis and breast cancer claims are outside the federal MDL’s current trial track but have not been dismissed as a category. These claims are actively worked up — records obtained, eligibility evaluated, and status monitored — and are positioned for the paths that remain open, including individual filing and any broader resolution.

Here is the record behind every part of it.

When the Judicial Panel on Multidistrict Litigation transferred these cases in February 2023, the injuries it named included “uterine, ovarian, or breast cancer, endometriosis, uterine fibroids, or other injuries to the reproductive system” (quoted at Dkt. 291 at 2). Fibroids were in the scope of the MDL 3060 from day one.

What changed was the trial track. On November 13, 2024, ruling on the plaintiffs’ own omnibus motion, the court dismissed with prejudice non-cancer injuries claimed alongside a withdrawn cancer claim by plaintiffs who did not have a cancer diagnosis — “to the extent any member Plaintiff claimed any other injury, including but not limited to fibroids or endometriosis” (Dkt. 946). But the same order draws a line in footnote 5, and that line is the whole point: it describes the situation where “the individual plaintiff is asserting only fibroids or endometriosis,” and says of the dismissal category that “[t]he case is clearly not limited to the three identified cancers.”

In plain terms: a fibroid claim bundled underneath a cancer claim the plaintiff did not actually have went away. A standalone fibroid claim was not swept up by that order. And the bellwether cases the court selected in April 2026 are cancer cases (Dkts. 1781, 1944), which is why fibroid claims are not on the trial calendar today.

Why the honest version helps you

It seems like you have already been shown a fibroid payout table with a number on it. Most pages on this search either promise a fibroid payout or quietly omit that the trial track is cancer-only — and at least one site publishing a fibroid tier table says elsewhere on the same site that it takes only cancer claims. If a firm tells you a fibroid claim is heading to trial in this MDL, you can check that against the court’s own bellwether order in minutes.

What a fibroid claim gets is real but specific: records obtained and reviewed, eligibility evaluated against the litigation and your state’s filing deadline, the docket monitored, and the claim positioned for the paths that stay open. There is no resolution today. You will be told that at the start rather than after you have handed over your records.

There is also live appellate law on the fibroid side. In October 2025 the Georgia Supreme Court held in Burroughs v. Strength of Nature Global, LLC and Burroughs v. L’Oreal USA, Inc. that Georgia’s ten-year statute of repose runs per unit sold, not from the earliest sale in a product line — reviving the claim of a woman who used relaxers from 1995 to 2014 and was diagnosed with uterine fibroids in 2018. That decision is about fibroids, and it went the plaintiff’s way.

What the research says about relaxers and fibroids

The Black Women’s Health Study is the study to know. Wise and colleagues followed 23,580 premenopausal participants from 1997 to 2009 — 199,991 person-years — and identified 7,146 incident cases of uterine leiomyomata, 4,630 confirmed by ultrasound and 2,516 by surgery. Ever-use of hair relaxers versus never-use produced an incidence rate ratio of 1.17 (95% confidence interval 1.06 to 1.30). The authors reported positive trends for frequency (P<0.001), duration (P=0.015) and scalp burns (P<0.001), and found risk unrelated to age at first use or to formulation type.

Two things stand out. The scalp-burn trend matters because burns are the risk most women were actually warned about — nobody was told the risk was anything worse than a burn, and the authors treat those burns as a route by which chemicals reach the bloodstream rather than as the injury in themselves. And the association is modest in size, which is why a fibroid claim is a records-and-exposure case. Full cohort details and citations are in the study evidence ledger.

A 2024 systematic review of 17 studies concluded that “the available evidence regarding personal use of hair products and gynecological conditions is insufficient to determine whether a positive association exists.” That belongs here as much as the 1.17 does.

Study findings and adverse-event reports describe associations; they are not verified causation.

Hysterectomy, myomectomy, and why treatment history matters

Fibroid claims are evaluated on what the fibroids did and what was done about them. Records that carry weight: ultrasound and MRI reports, operative reports for myomectomy, uterine fibroid embolization, endometrial ablation or hysterectomy, transfusion records for anemia from heavy bleeding, fertility treatment records, and time out of work.

A hysterectomy — particularly young, and particularly where it closed off the possibility of having children — is the single fact that most changes how a fibroid claim is assessed. If you had one, the operative report and pathology are the first documents anyone will want.

Do you qualify?

Whether your claim is a fibroid or a cancer claim changes what happens next, which is why both are asked about together. The eligibility walkthrough sets out the sequence. The first step is about two minutes, costs nothing, and asks nothing you have to look up first — records are requested for you, with your authorization.

What this page is not

This page is legal information, not medical advice, and it does not diagnose anything. Questions about your health belong with your own doctor.

No hair relaxer settlement has been announced and no one has been paid. Any page that quotes a dollar figure is estimating. Fibroid “payout” tables are especially untethered — the settlement page explains why.

Consultations are free and confidential, and there is no fee unless there is a recovery. Some matters may be referred to or handled with other law firms.

A claim here is against the companies that made and sold the product — not against a salon, not against whoever applied it, and not against you for having used it. Would it be wrong to find out where a fibroid claim actually stands, from someone willing to tell you it is not on the trial calendar? You get an answer either way.

Frequently Asked Questions

Cases are handled on a contingent-fee basis: no fee unless there is a recovery. The attorney’s fee is a percentage of the gross recovery, calculated before case expenses are deducted. Case expenses are advanced by the firm and reimbursed to the firm out of the recovery only if there is a recovery. You have no liability for court costs or litigation expenses if there is no recovery, unless a court directs otherwise.